Dianthus Therapeutics grants 87,000 inducement stock options at $106.02 per share

Reuters2026/08/03 22:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Dianthus Therapeutics granted inducement equity awards on Aug. 3, 2026 to six newly hired non-executive employees.
Non-qualified stock options cover 87,000 shares, carry a 10-year term, set at an exercise price of $106.02 per share.
Vesting schedules 25% at the first anniversary, then monthly installments over the next 36 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031800PRIMZONEFULLFEED9802825) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Dianthus Therapeutics grants 87,000 inducement stock options at $106.02 per share

You may also like

Crypto prices